Live Breaking News & Updates on Professor Ji Jiafu

Stay updated with breaking news from Professor ji jiafu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Supplemental New Drug Application for Akeso's Cadonilimab (PD-1/CTLA-4) Accepted by NMPA for First-line Treatment of Gastric Cancer

/PRNewswire/ Akeso (9926.HK) announced the China National Medical Products Administration (NMPA) has accepted the supplemental new drug application (sNDA). ....

Lin Shen , Hong Kong , Ji Jiafu , Yu Xia , Akeso Inc , China National Medical Products Administration , University Cancer Hospital , Professor Ji Jiafu , Peking University Cancer , Professor Lin Shen , Summit Therapeutics , Main Board , Stock Exchange ,

Patient Enrollment Completed for Phase III Clinical Trial of Akeso's Cadonilimab in Treatment of Gastric Cancer

/PRNewswire/ Akeso, Inc. (9926.HK) announced that patient enrollment has been completed for its pivotal Phase III clinical trial for cadonilimab. ....

Ji Jiafu , Prnewswire Akeso Inc , Akeso Inc , Professor Ji Jiafu , Peking Cancer Hospital ,